Bajaj Healthcare Ltd vs Fabino Enterprises Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Bajaj Healthcare Ltd is ₹ 274.95 as of 18 May 15:30 . The P/E Ratio of Bajaj Healthcare Ltd is 0 as of March 2023 .The P/E Ratio of Fabino Enterprises Ltd is 600 as of March 2023 . The Market Cap of Bajaj Healthcare Ltd is ₹ 0 crore as of March 2023 .The Market Cap of Fabino Enterprises Ltd is ₹ 6.3 crore as of March 2023 . The revenue of Bajaj Healthcare Ltd for the Mar '26 is ₹ 156.01 crore as compare to the Dec '25 revenue of ₹ 162.87 crore. This represent the decline of -4.21% The revenue of Fabino Enterprises Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Bajaj Healthcare Ltd for the Mar '26 is ₹ -11.05 crore as compare to the Dec '25 ebitda of ₹ 31.9 crore. This represent the decline of -134% The ebitda of Fabino Enterprises Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Bajaj Healthcare Ltd changed from ₹ 7.13 crore to ₹ -22.85 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Fabino Enterprises Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The Dividend Payout of Bajaj Healthcare Ltd changed from 4.57 % on March 2021 to 7.99 % on March 2025 . This represents a CAGR of 11.82% over 5 yearsThe Dividend Payout of Fabino Enterprises Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Bajaj Healthcare Ltd

Incorporated in 1993, Maharashtra-based Bajaj Healthcare Limited is one of India's large scale and vertically integrated pharmaceutical manufacturer for quality-conscious customers.
The Company is engaged in the manufacturing and exporting of Active Pharmaceutical Ingredient (APIs), Intermediates, Finished Dosage Forms & Nutraceuticals. Company commenced its operations in 1993 with a single unit at Tarapur.
It became a public company in 2005 and listed its shares in the Indian stock exchanges in 2016. With Headquartered in Thane, Company has established 3 API plants in Gujarat and Maharashtra.
It has 4 units for APIs/ intermediates and one unit for formulation, which are designed to meet the requirements of both advanced as well as emerging market opportunities.
In 2008, the Company acquired Formulations plant at Manjusar, Vadodara and have converted it into WHO-GMP compliant facility.

About Fabino Enterprises Ltd

Fabino Enterprises Limited is a growing pharmaceutical company promoted by Atul Kumar Jain.
The Company was incorporated as 'Fabino Life Sciences Private Limited' on October 27, 2011 with the Registrar of Companies, Delhi and Haryana.
Subsequently, the Company got converted to Public Limited Company and the name of Company was changed to 'Fabino Life Sciences Limited'.
A fresh Certificate of Incorporation was issued on March 21, 2015 by the Registrar of Companies, Delhi. The Company operate in the business of manufacturing, marketing of pharmaceutical, allopathic, herbal, veterinary, and other consumer products like, packing, trading, etc.
The core business is marketing of pharmaceutical formulation & products in domestic market through its own distribution network and sales force under own brand name, getting Ayurvedic formulations manufactured through loan licensing facilities, packing, labeling etc.

FAQs for the comparison of Bajaj Healthcare Ltd and Fabino Enterprises Ltd

Which company has a larger market capitalization, Bajaj Healthcare Ltd or Fabino Enterprises Ltd?

Market cap of Bajaj Healthcare Ltd is 925 Cr while Market cap of Fabino Enterprises Ltd is 4 Cr

What are the key factors driving the stock performance of Bajaj Healthcare Ltd and Fabino Enterprises Ltd?

The stock performance of Bajaj Healthcare Ltd and Fabino Enterprises Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bajaj Healthcare Ltd and Fabino Enterprises Ltd?

As of May 18, 2026, the Bajaj Healthcare Ltd stock price is INR ₹274.95. On the other hand, Fabino Enterprises Ltd stock price is INR ₹20.31.

How do dividend payouts of Bajaj Healthcare Ltd and Fabino Enterprises Ltd compare?

To compare the dividend payouts of Bajaj Healthcare Ltd and Fabino Enterprises Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.